Publication Type: Advocacy
Letter of support from NDP Leader Jack Layton re: Global Treatment Access Group
“Thank you for writing me in support of the Make Poverty History campaign’s work at the 16th International AIDS Conference in Toronto. Clearly, Prime Minister Stephen Harper’s absence speaks volumes as to where he places the HIV/AIDS crisis among his priorities. In contrast, NDP Caucus members Bill Siksay, Libby Davies, Olivia Chow, Alexa McDonough, and … Read more
Avoiding the injection invective – Ottawa Citizen commentary
In order to minimize the problem, argues Joanne Csete, African nations must refuse to submit to the knee-jerk response to demonize drug users.
Will it Deliver? WTO rules and Canada’s law on compulsory licensing – The continuing challenge of scaling up treatment access – Event at XVI International AIDS Conference
At this session, Brigitte Zirger (Health Canada), Prof. David H. Mwakyusa (Minister for Health and Social Welfare – Tanzania), Bruce Clark (Apotex), Anil Soni (Clinton Foundation), Rachel Kiddell-Monroe (Médecins Sans Frontières) and Richard Elliott (Canadian HIV/AIDS Legal Network) will present their perspectives on their experience with the Canadian law and the 2003 WTO decision, and … Read more
Letter to Prime Minister Stephen Harper re: Global Treatment Access Group
Download and send this letter to the Prime Minister and your local member of Parliament.
Letter to Industry Canada re: Addition of oseltamivir phosphate to Schedule 1 to the Patent Act
“On July 1, 2006 the Departments of Industry and Health published, in Part I of the Canada Gazette, the proposed text of an order to amend Schedule 1 to the Patent Act to add “oseltamivir phosphate”, in both capsule form as well as in powder for oral suspension, to the list of patented pharmaceutical products … Read more
Letter to federal Health Minister Tony Clement re: Insite
“As Canada’s national HIV/AIDS organizations and as partners in the Federal Initiative on HIV/AIDS, we write to ask you to extend the regulatory exemption allowing Insite, Vancouver’s safe injection facility, to continue its life-saving work…”